default author photo

Flora Donati

University of Paris-Saclay - Institut Pasteur

75724 Paris CEDEX 15

France

SCHOLARLY PAPERS

1

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Sotrovimab Retains Activity Against SARS-CoV-2 Omicron Variant BQ.1.1 in a Nonhuman Primate Model

Number of pages: 6 Posted: 06 Apr 2023
University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Aix Marseille Université - Emerging Viruses Unit, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Aix Marseille Université - Emerging Viruses Unit, Aix Marseille Université - Emerging Viruses Unit, University of Paris-Saclay - Molecular Genetics of RNA Viruses and University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT)
Downloads 77 (823,616)

Abstract:

Loading...

sars-cov2, sotrovimab, Non human primate